Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Forecasted Growth Rate and Market Size of the Minimally Invasive Urinary Incontinence Device Market?
The market size of minimally invasive devices for urinary incontinence has seen a robust growth in the past few years. The market is projected to rise from $1.15 billion in 2024 to $1.25 billion in 2025, marking a compound annual growth rate (CAGR) of 9.2%. This growth during the historical period stems from factors such as increased awareness of treatments for urinary incontinence, more access to minimally invasive procedures, an increasing population of older individuals needing bladder control solutions, the introduction of innovative sling and bulking agent systems, and enhanced surgical training for managing incontinence.
In the coming years, the market size for minimally invasive urinary incontinence devices is anticipated to witness considerable growth, ballooning to $1.76 billion by 2029 with a CAGR of 8.9%. Factors contributing to the growth during the forecasted timeframe include the widening scope of reimbursement support for minor urinary treatments, a rising demand for outpatient as well as same-day procedures, enhanced focus on patient comfort and faster recovery, growing acceptance in developing economies, and the increasing prevalence of incontinence owing to lifestyle and medical ailments. Key market trends for the forecasted period include ongoing innovation in device miniaturization and material safety, the incorporation of wireless monitoring and control features, R&D in nerve stimulation technologies, progress in adjustable and reusable sling systems, and the use of 3D printing for tailored urinary devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27350&type=smp
Which Factor Is Shaping The Future Of The Minimally Invasive Urinary Incontinence Device Market?
The rise in cases of prostate cancer is predicted to stimulate the expansion of the minimally invasive urinary incontinence device market. Prostate cancer, characterized by the unchecked proliferation of cells in the prostate gland, can influence both urinary and reproductive health. The increasing prevalence of this disease is primarily due to an aging male demographic, given that older age is a major risk factor. Minimally invasive urinary incontinence devices are instrumental in managing urinary complications linked to prostate cancer as they provide specialized support to manage bladder leakage, reinstate normal urinary function, and significantly enhance the overall quality of life for patients in treatment or recovery. For example, the Centers for Disease Control and Prevention, a government agency in the United States, reported in June 2025 that there had been an estimated 255,395 new cases of prostate cancer diagnosed in 2022 in the United States. In 2023, the disease had resulted in about 33,881 men’s deaths. Therefore, the increasing cases of prostate cancer are fueling the expansion of the minimally invasive urinary incontinessce device market.
What Is The Segment-Wise Breakdown Of The Minimally Invasive Urinary Incontinence Device Market?
The minimally invasive urinary incontinence device market covered in this report is segmented
1) By Type: Tension Free Vaginal Tape (TVT), Tension Free Vaginal Tape (TVT) Obturator System, Other Types
2) By Age Group: Adults (18-65 years), Senior Population (65 Years And Above), Pediatric Population
3) By End-User: Hospitals, Clinics, Home Healthcare Settings, Research Institutions
Subsegments:
1) By Tension Free Vaginal Tape (TVT): Mid Urethral Sling, Retropubic Sling, Single Incision Sling
2) By Tension Free Vaginal Tape Obturator System (TVTO): Inside Out Approach, Outside In Approach
3) By Other Types: Bulking Agents, Artificial Urinary Sphincter, Sling Systems
Which Trends Are Redefining The Future Landscape Of The Minimally Invasive Urinary Incontinence Device Industry?
Prominent entities in the domain of minimally invasive urinary incontinence devices are directing their efforts towards the creation of advanced products. These include neuromodulation therapy devices, which present effective, long-term solutions requiring minimal surgical procedures. Neuromodulation therapy devices are implants designed to stimulate bladder control nerves, enhancing bladder function and alleviating incontinence by reducing unintended leakage. For instance, in December of 2023, BlueWind Medical Ltd., a neurostimulation device producer based in the US, unveiled its Revi implantable tibial neuromodulation (iTNM) device. This battery-free, minimally invasive implant aims to alleviate urge urinary incontinence (UUI) through stimulation of the posterior tibial nerve. The device, which is planted near the ankle during a single-opportunity outpatient procedure, is activated by a lightweight wearable. This allows patients to manage their symptoms conveniently in a home setting. This product introduction attests to the continuing trend of novel, patient-centric neuromodulation solutions in the urinary incontinence device market.
Which Companies Hold The Largest Market Share In The Minimally Invasive Urinary Incontinence Device Sector?
Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA.
Get The Full Report Here:
How Does Regional Performance Compare Across The Minimally Invasive Urinary Incontinence Device Industry?
North America was the largest region in the minimally invasive urinary incontinence device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27350&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model